ProteoFormiX

Modern mass spectrometry developments hold significant potential for the discovery and sensitive detection of innovative (sets of) biomarkers which will allow rapid and accurate diagnosis of multiple disorders simultaneously in a single patient’s small-volume sample.

ProteoFormiX is running a mass spectrometry-based top-down proteomics technology platform to identify such disease-associated proteoforms (e.g., peptides) in clinically sampled human body fluids and tissues.

Focus area
Platform / research tool